Actual Use Trial of Ibuprofen 400 mg

Phase 3 Completed 738 enrolled Pfizer

Open-label

Summary

This is an open label, multicenter, 30 day study designed to mimic an OTC like environment in which subjects will use the product after making a purchase decision about ibuprofen 400 mg caplets based only on their reading of the Drug Facts Label (DFL) and other information on the package.

Timeline

Start: 2014-11
Primary completion: 2015-05
Completion: 2015-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ibuprofen	Small molecule	400 mg	—

Indications

No indication recorded.